These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 31401877)

  • 41. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia.
    Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The soluble fms-like tyrosin kinase-1 (sFLT-1) to placental growth factor (PIGF) ratio as a possible indicator for the severity of preeclampsia - single institution experience.
    Müller A; Horvat V; Vulin M; Mandić S; Šerić V; Vidosavljević D
    Med Glas (Zenica); 2019 Feb; 16(1):53-59. PubMed ID: 30680983
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cost effectiveness of the sFlt1/PlGF ratio test as an adjunct to the current practice of evaluating suspected preeclampsia in the United States.
    Khosla K; Espinoza J; Perlaza L; Gencay M; Mueller AL; Harris JM; Wolf C; Posnett JW; Woelkers DA; Rana S
    Pregnancy Hypertens; 2021 Dec; 26():121-126. PubMed ID: 34749060
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic Biomarkers in Women With Suspected Preeclampsia in a Prospective Multicenter Study.
    Duckworth S; Griffin M; Seed PT; North R; Myers J; Mackillop L; Simpson N; Waugh J; Anumba D; Kenny LC; Redman CWG; Shennan AH; Chappell LC
    Obstet Gynecol; 2016 Aug; 128(2):245-252. PubMed ID: 27400001
    [TBL] [Abstract][Full Text] [Related]  

  • 45. sFlt-1, PlGF, sFlt-1/PlGF ratio and uterine artery Doppler for preeclampsia diagnostics.
    Tarasevičienė V; Grybauskienė R; Mačiulevičienė R
    Medicina (Kaunas); 2016; 52(6):349-353. PubMed ID: 27940029
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of agreement of placental growth factor (PlGF) tests and the soluble FMS-like tyrosine kinase 1 (sFlt-1)/PlGF ratio, comparison of predictive accuracy for pre-eclampsia, and relation to uterine artery Doppler and response to aspirin.
    Navaratnam K; Abreu P; Clarke H; Jorgensen A; Alfirevic A; Alfirevic Z
    J Matern Fetal Neonatal Med; 2019 Jan; 32(2):179-187. PubMed ID: 28851242
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of angiogenic factors in the decision to admit women with suspected preeclampsia.
    Suresh S; Mueller A; Salahuddin S; Naseem H; Dhir R; Rana S
    Pregnancy Hypertens; 2020 Jul; 21():124-131. PubMed ID: 32505096
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analytical evaluation of the novel soluble fms-like tyrosine kinase 1 and placental growth factor assays for the diagnosis of preeclampsia.
    van Helden J; Weiskirchen R
    Clin Biochem; 2015 Nov; 48(16-17):1113-9. PubMed ID: 26129879
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Soluble Fms-like tyrosine kinase-1 to placental growth factor ratio in mid-pregnancy as a predictor of preterm preeclampsia in asymptomatic pregnant women.
    Forest JC; Thériault S; Massé J; Bujold E; Giguère Y
    Clin Chem Lab Med; 2014 Aug; 52(8):1169-78. PubMed ID: 24535301
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Placental growth factor (PlGF) and sFlt-1 during pregnancy: physiology, assay and interest in preeclampsia.
    Lecarpentier É; Vieillefosse S; Haddad B; Fournier T; Leguy MC; Guibourdenche J; Tsatsaris V
    Ann Biol Clin (Paris); 2016 Jun; 74(3):259-67. PubMed ID: 27237799
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Angiogenic profile in the Finnish Genetics of Pre-Eclampsia Consortium (FINNPEC) cohort.
    Jääskeläinen T; Heinonen S; Hämäläinen E; Pulkki K; Romppanen J; Laivuori H;
    Pregnancy Hypertens; 2018 Oct; 14():252-259. PubMed ID: 29803331
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Economic evaluation of sFlt-1/PlGF ratio test in pre-eclampsia prediction and diagnosis in two Brazilian hospitals.
    Figueira SF; Wolf C; D'Innocenzo M; de Carvalho JPV; Barbosa MG; Zlotnik E; Cordioli E
    Pregnancy Hypertens; 2018 Jul; 13():30-36. PubMed ID: 30177068
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum soluble FMS-like tyrosine kinase 1 and placental growth factor concentration as predictors of preeclampsia in high risk pregnant women.
    Hanita O; Alia NN; Zaleha AM; Nor Azlin MI
    Malays J Pathol; 2014 Apr; 36(1):19-26. PubMed ID: 24763231
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased serum levels of sFlt-1/PlGF ratio in preeclamptic women with onset at <32 weeks compared with ≥32 weeks.
    Suzuki H; Hirashima C; Nagayama S; Takahashi K; Yamamoto T; Matsubara S; Ohkuchi A
    Pregnancy Hypertens; 2018 Apr; 12():96-103. PubMed ID: 29674208
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The sFlt-1/PlGF ratio associates with prolongation and adverse outcome of pregnancy in women with (suspected) preeclampsia: analysis of a high-risk cohort.
    Saleh L; Verdonk K; Jan Danser AH; Steegers EA; Russcher H; van den Meiracker AH; Visser W
    Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():121-6. PubMed ID: 26927894
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic Value of Angiogenic Markers in Pregnant Women With Chronic Hypertension.
    Binder J; Palmrich P; Kalafat E; Pateisky P; Öztürk E; Mittelberger J; Khalil A
    J Am Heart Assoc; 2021 Sep; 10(17):e020631. PubMed ID: 34459247
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhancing the value of the sFlt-1/PlGF ratio for the prediction of preeclampsia: Cost analysis from the Belgian healthcare payers' perspective.
    Chantraine F; Van Calsteren K; Devlieger R; Gruson D; Keirsbilck JV; Dubon Garcia A; Vandeweyer K; Gucciardo L
    Pregnancy Hypertens; 2021 Dec; 26():31-37. PubMed ID: 34482271
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.
    Lim JH; Kim SY; Park SY; Yang JH; Kim MY; Ryu HM
    Obstet Gynecol; 2008 Jun; 111(6):1403-9. PubMed ID: 18515525
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Added prognostic value of longitudinal changes of angiogenic factors in early-onset severe pre-eclampsia: a prospective cohort study.
    Peguero A; Fernandez-Blanco L; Mazarico E; Benitez L; Gonzalez A; Youssef L; Crispi F; Hernandez S; Figueras F
    BJOG; 2021 Jan; 128(2):158-165. PubMed ID: 32593222
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical Assessment of Soluble FMS-Like Tyrosine Kinase-1/Placental Growth Factor Ratio for the Diagnostic and the Prognosis of Preeclampsia in the Second Trimester.
    Chelli D; Hamdi A; Saoudi S; Jenayah AA; Zagre A; Jguerim H; Bedis C; Sfar E
    Clin Lab; 2016 Oct; 62(10):1927-1932. PubMed ID: 28164532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.